Journal ArticleDOI
Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus
TLDR
It is confirmed that CNS disease in SLE is significantly associated with the presence of aPL antibodies, and the CNS manifestations can occur in about half of SLE patients without any other evidence of lupus activity.About:
This article is published in The American Journal of Medicine.The article was published on 1995-10-01. It has received 185 citations till now. The article focuses on the topics: Lupus erythematosus & Systemic lupus erythematosus.read more
Citations
More filters
Journal ArticleDOI
The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes
Matthew H. Liang,Michael Corzillius,Sang Cheol Bae,Robert A. Lew,Paul R. Fortin,Caroline Gordon,David A. Isenberg,Graciela S. Alarcón,Karin V. Straaton,Judah A. Denburg,Susan D. Denburg,John M. Esdaile,Bonnie I. Glanz,Elizabeth W. Karlson,Shahram Khoshbin,Malcolm P. Rogers,Peter H. Schur,John G. Hanly,Elizabeth Kozora,Sterling G. West,Robert G. Lahita,Michael D. Lockshin,Joseph M. McCune,Patricia M. Moore,Michelle Petri,W. Neal Roberts,Jorge Sánchez-Guerrero,Martin Veilleux,Robin L. Brey,Wayne D. Cornblath,Christopher M. Filley,John D. Fisk,Pontus Harten,Elaine M. Hay,Grant L. Iverson,Steven R. Levine,Elizabeth Waterhouse,Daniel J. Wallace,John B. Winer +38 more
TL;DR: The American College of Rheumatology Nomenclature for NPSLE provides case definitions for 19 neuropsychiatric syndromes seen in SLE, with reporting standards and recommendations for laboratory and imaging tests.
Journal ArticleDOI
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.
John M. Esdaile,Michal Abrahamowicz,Tamara Grodzicky,Yin Li,Constantina Panaritis,Roxane du Berger,Robert Côté,Steven A. Grover,Paul R. Fortin,Ann E. Clarke,Jean-Luc Senécal +10 more
TL;DR: There is a substantial and statistically significant increase in CHD and stroke in SLE that cannot be fully explained by traditional Framingham risk factors alone.
Journal Article
Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.
Giovanni Sanna,Maria Laura Bertolaccini,Maria José Cuadrado,Hana Laing,Munther A. Khamashta,Alessandro Mathieu,Graham R. V. Hughes +6 more
TL;DR: The new ACR criteria for NPSLE are useful to define NP manifestations in SLE with accuracy and are significantly associated with antiphospholipid antibodies, which are independently associated with CVD, headache, and seizures.
Journal ArticleDOI
Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study.
Linda T. Hiraki,Susanne M. Benseler,Pascal N. Tyrrell,Diane Hebert,Elizabeth Harvey,Earl D. Silverman +5 more
TL;DR: The most common clinical manifestations were arthritis, malar rash, nephritis, and central nervous system (CNS) disease, and patients with both renal and CNS disease had the highest SLE Disease Activity Index (SLEDAI) scores at diagnosis.
Journal ArticleDOI
Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations
TL;DR: Evidence supports the use of glucocorticoids alone or in combination with immunosuppressive therapy for SLE-related neuropsychiatric disease, and antiplatelet and/or anticoagulation therapy is recommended for NPSLE manifestations related to antiphospholipid antibodies.
References
More filters
Journal ArticleDOI
The 1982 revised criteria for the classification of systemic lupus erythematosus
Eng M. Tan,Alan S. Cohen,James F. Fries,Alfonse T. Masi,Dennis J. McShane,Naomi F. Rothfield,Jane G. Schaller,Norman Talal,Robert Winchester +8 more
TL;DR: The 1971 preliminary criteria for the classification of systemic lupus erythematosus (SLE) were revised and updated to incorporate new immunologic knowledge and improve disease classification and showed gains in sensitivity and specificity.
Journal ArticleDOI
Classification of cerebrovascular diseases iii
Jack P. Whisnant,Jeffrey R. Basford,Eugene F. Bernstein,Edward S. Cooper,Mark L. Dyken,J. Donald Easton,John R. Little,John R. Marler,Clark H. Millikan,Carol K. Petito,Thomas R. Price,Marcus E. Raichle,James T. Robertson,Brian Thiele,Michael D. Walker,Robert A. Zimmerman +15 more
Journal ArticleDOI
Thrombosis, abortion, cerebral disease, and the lupus anticoagulant.
TL;DR: Few diabetics register on the Disabled Persons Register, but those with disabling complications may find it advantageous to do so and to seek the advice of their local disablement resettlement officer.
Journal ArticleDOI
The neurological manifestations of systemic lupus erythematosus.
Journal Article
Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986.
TL;DR: This study shows that properly performed ELISA or SRIA assays can be used to provide an accurate, reproducible, and quantitative measure of IgG and IgM aCL concentration in serum samples.
Related Papers (5)
The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes
Matthew H. Liang,Michael Corzillius,Sang Cheol Bae,Robert A. Lew,Paul R. Fortin,Caroline Gordon,David A. Isenberg,Graciela S. Alarcón,Karin V. Straaton,Judah A. Denburg,Susan D. Denburg,John M. Esdaile,Bonnie I. Glanz,Elizabeth W. Karlson,Shahram Khoshbin,Malcolm P. Rogers,Peter H. Schur,John G. Hanly,Elizabeth Kozora,Sterling G. West,Robert G. Lahita,Michael D. Lockshin,Joseph M. McCune,Patricia M. Moore,Michelle Petri,W. Neal Roberts,Jorge Sánchez-Guerrero,Martin Veilleux,Robin L. Brey,Wayne D. Cornblath,Christopher M. Filley,John D. Fisk,Pontus Harten,Elaine M. Hay,Grant L. Iverson,Steven R. Levine,Elizabeth Waterhouse,Daniel J. Wallace,John B. Winer +38 more